Rare-endocrine buyers have paid roughly $2.9 billion and approximately $10.0 billion for acquisition

PRINCETON, N.J., May 18, 2026 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a bio

Palatin Technologies, Inc. (PTN) Q3 2026 Earnings Call Transcript

Advancing MC4R-based obesity programs for rare obesity disorders with a focus on improved tolerabili

Palatin Technologies (NYSEAMERICAN:PTN) executives highlighted recent financing activity, progress i

Palatin Technologies, Inc. (PTN) Q2 2026 Earnings Call Transcript

Advancing differentiated MC4R-based obesity programs into clinical development Melanocortin-based ob

Palatin Technologies shares rose in after-hours trading as Janus Henderson Group and its subsidiary

Pre-Market Stock Futures: The futures are trading higher on Wednesday after a stellar day across Wal

Palatin Technologies, Inc. (OTC:PTN) Q1 2026 Earnings Call November 13, 2025 11:00 AM EST Company Pa

Significant progress on multiple fronts – obesity pipeline advancing towards the clinic, out-licensi

Trading of Palatin's common shares resumed trading on NYSE today, November 12, 2025, under the symbo

Oral MC4R agonist PL7737 demonstrated robust weight loss, safety, and high oral bioavailability in p

$15.8 million at closing with up to an additional $15.8 million upon the cash exercise of the milest

Collaboration focused on developing potential first-in-class melanocortin receptor targeted treatmen

Boehringer and Palatin Technologies team up to develop potential first-in-class melanocortin recepto

PRINCETON, N.J. , Aug. 8, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (OTCQB: PTNT), today annou

Oral PL7737 monotherapy produced rapid and significant weight loss after just 4 days of treatment Co

Palatin Technologies, Inc. (PTN) Q3 2025 - Earnings Conference Call May 14, 2025 11:00 AM ET Company

Findings highlight PL9654 and PL9655's potential to treat diabetic retinopathy through inflammation

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earning

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $

  During Tuesday's session, 275 companies made new 52-week lows.

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is estimated to report earnings for its f

  OnFriday, 143 stocks hit new 52-week lows.

  On Tuesday, 298 companies achieved new lows for the year.

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly

Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.

  On Thursday, 529 companies set new 52-week lows.

Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Sc

Gainers USA Truck, Inc. (NASDAQ: USAK) shares jumped 111% to $30.76. DB Schenker and USA Truck a

  On Tuesday, 951 companies hit new 52-week lows.

    This morning 533 companies reached new 52-week highs.

    Before 10 a.m. ET on Wednesday, 375 companies hit new 52-week highs.

  Wednesday morning saw 335 companies set new 52-week highs.

Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Wednesday

Stocks That Hit 52-Week Lows On Monday

Stocks That Hit 52-Week Lows On Friday

Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Wednesday

Stocks Which Set New 52-Week Low Yesterday Tues., Nov. 27, 2018

Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 26, 2018